IFG Advisory LLC lessened its holdings in Clorox Co (NYSE:CLX) by 25.7% during the first quarter, Holdings Channel reports. The fund owned 2,651 shares of the company’s stock after selling 919 shares during the quarter. IFG Advisory LLC’s holdings in Clorox were worth $425,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Athena Capital Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter worth approximately $25,000. Meeder Asset Management Inc. purchased a new stake in shares of Clorox during the 4th quarter worth approximately $26,000. Capital Financial Planning LLC purchased a new stake in shares of Clorox during the 4th quarter worth approximately $32,000. Paragon Capital Management LLC purchased a new stake in shares of Clorox during the 1st quarter worth approximately $35,000. Finally, Penserra Capital Management LLC purchased a new stake in shares of Clorox during the 1st quarter worth approximately $36,000. Institutional investors own 77.92% of the company’s stock.
CLX has been the subject of several research analyst reports. Zacks Investment Research lowered shares of Clorox from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. Wells Fargo & Co restated a “hold” rating and set a $157.00 price target on shares of Clorox in a research note on Monday, February 4th. Citigroup set a $171.00 price target on shares of Clorox and gave the stock a “hold” rating in a research note on Tuesday, February 5th. Bank of America restated a “neutral” rating and set a $154.00 price target (down previously from $165.00) on shares of Clorox in a research note on Thursday, May 2nd. Finally, JPMorgan Chase & Co. lowered shares of Clorox from a “neutral” rating to an “underweight” rating and decreased their price target for the stock from $159.00 to $139.00 in a research note on Monday, April 8th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Clorox currently has an average rating of “Hold” and a consensus target price of $149.29.
CLX stock opened at $149.63 on Friday. Clorox Co has a 12-month low of $119.78 and a 12-month high of $167.70. The stock has a market capitalization of $19.06 billion, a price-to-earnings ratio of 23.90, a PEG ratio of 4.31 and a beta of 0.31. The company has a debt-to-equity ratio of 2.93, a quick ratio of 0.66 and a current ratio of 1.10.
Clorox (NYSE:CLX) last announced its earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.03). The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 EPS. As a group, equities analysts predict that Clorox Co will post 6.29 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be paid a dividend of $1.06 per share. This is a positive change from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.83%. Clorox’s payout ratio is presently 61.34%.
In other news, SVP Andrew J. Mowery sold 5,340 shares of Clorox stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $156.44, for a total transaction of $835,389.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.40% of the company’s stock.
TRADEMARK VIOLATION WARNING: “IFG Advisory LLC Has $425,000 Position in Clorox Co (CLX)” was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thestockobserver.com/2019/05/25/ifg-advisory-llc-has-425000-position-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: Trading on Margin
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.